Welcome to RLPSecurties

Stock Quotes	Board Of Directors	Income Statement	Directors Report	Change Name	Quarterly Results
High/Low	Share Holding	Balance Sheet	Auditors Report	Book Closure	Half Yearly Results
Company Profile	MF Holding	Cash Flow	Notes to Accounts	Dividend Details	Technical Chart
Locations	Investor Returns	Ratios	Banker's/Auditor's	ADR/GDR Prices	Peer Comparision

Marksans Pharma Ltd.	LIVE QUOTES

NSE: MARKSANSEQ BSE: 524404ISIN: INE750C01026INDUSTRY: Pharmaceuticals

BSE

Rs 170.60

Open: 178.75

Today's Range 169.05

185.40

NSE
Rs 170.45
-6.25 ( -3.67 %)

-5.90 ( -3.46 %)

Prev Close: 176.50

52 Week Range 70.20

185.40

Registered Address

Registered Office : 11th Floor, Grandeur, Veera Desai Extension Road, Oshiwara, Andheri (West),

Mumbai, Maharashtra - 400053

Tel: 022-40012000

Fax: 022-40012011

Email : companysecretary@marksanspharma.com

Website : http://www.marksanspharma.com

Key Officials

Name	Designation
Mr. Harshavardhan Panigrahi	Company Secretary & Manager - Legal
Mr. Jitendra Sharma	Chief Financial Officer

Listings

BSE , NSE ,

StandaloneConsolidated

Quarterly Trends - Standalone

Rs. in Crs.

Financial Year	Dec 23	Sep 23	Jun 23
Sales	241.36	204.67	182.04
Other Income	1.33	15.93	32.62
Total Expenses	177.28	149.81	136.33
Depreciation	8.43	8.50	4.72
Taxation	9.31	13.21	10.20
Net Profit / Loss	25.29	31.29	44.19
Equity Capital	45.32	45.32	45.32

Half Yearly Balance Sheet - Standalone

Rs. in Crs.

YearEnding	Mar 23	Mar 22	Mar 21
Face Value	1	1	1
Equity Share Capital	45.32	40.93	40.93
Reserves and Surplus	1066.01	743.74	558.79
Total Non-Current Liabilities	17.00	14.41	23.94
Total Current Liabilities	216.54	166.53	94.90
Total Capital And Liabilities	1344.86	965.61	718.56
Total Non-Current Assets	431.10	375.75	369.32
Total Current Assets	913.76	589.86	349.24
Total Assets	1344.86	965.61	718.56

Quarterly Trends - Consolidated

Rs. in Crs.

Financial Year	Dec 23	Sep 23	Jun 23
Sales	586.13	531.24	500.03
Other Income	4.80	19.00	10.10
Total Expenses	371.80	332.00	283.36
Depreciation	22.00	17.55	13.66
Taxation	29.69	29.92	26.39
Net Profit / Loss	82.97	83.85	70.44
Equity Capital	45.32	45.32	45.32

Half Yearly Balance Sheet - Consolidated

Rs. in Crs.

YearEnding	Mar 23	Mar 22	Mar 21
Face Value	1	1	1
Equity Share Capital	45.32	40.93	40.93
Reserves and Surplus	1699.85	1161.34	845.56
Minority Interest	19.91	20.70	18.86
Total Non-Current Liabilities	84.33	60.91	24.50
Total Current Liabilities	340.99	356.22	298.40
Total Capital And Liabilities	2190.39	1640.10	1228.25
Total Non-Current Assets	515.09	438.90	326.00
Total Current Assets	1675.30	1201.20	902.25
Total Assets	2190.39	1640.10	1228.25

Corporate News

Marksans Pharma - Announcement under Regulation 30 (LODR)-Pr...

Marksans Pharma has submitted to BSE the Shareholding Patter...

Marksans Pharma - Format of the Annual Disclosure to be made...

Marksans Pharma - Format of the Initial Disclosure to be mad...

Marksans Pharma - Compliances-Certificate under Reg. 74 (5) ...

Registrar Details

Bigshare Services Pvt. Ltd.

S6-2, 6th Floor, Pinnacle Business Park, Next to Ahura Centre, Ma

Mumbai,400093,Maharashtra

Tel : 022-62638200

Fax : 62638261

BSENSE

Market Performance

Exchange	BSE	NSE
Last Traded Price (Rs.)	170.60	170.45
Last Traded Date	18/04/2024	18/04/2024
Last Traded Time	-	-
Change (%)	-3.34%	-3.54%
Day's Open (Rs.)	178.75	178.30
Previous Close (Rs.)	176.50	176.70
Day's High (Rs.)	185.40	185.50
Day's Low (Rs.)	169.05	168.55
Total Traded Qty	711472	9565839
Value (Rs. In Lacs)	1265.72	17038.69
Bid Price (Rs.)	0.00	0.00
Bid Quantity
Offer Price (Rs.)	0.00	0.00
Offer Quantity
Exchange Code	524404	MARKSANSEQ
Exchange Group	A	OtherEQ

Board Meetings

Date	Purpose
13/02/2024	Quarterly Results
09/11/2023	Quarterly Results
11/08/2023	Quarterly Results

Share Holding Pattern as on 31/03/2024

Major Holder	No. of Shares	Percentage (%)
Promoters	198,711,733	43.85
Institutional Investors	94,021,892	20.75
Other Investors	20,357,400	4.49
General Public	140,072,721	30.91

Market

Derivatives

Mutual Fund

IPO

Quick Links

Marksans Pharma Ltd.

LIVE QUOTES